Peripheral Neuritis Treatment Market Report 2025 – Strategic Insights for Companies Seeking Expansion, Growth & Competitive Advantage
For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.
What are the growth projections for the peripheral neuritis treatment market from 2024 to 2029?
The peripheral neuritis treatment market size has grown strongly in recent years. It will grow from $1.84 billion in 2024 to $1.93 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to increase in healthcare expenditure, the increase in chronic diseases, the growing burden of diseases associated with peripheral neuritis, higher prevalence rate of diabetic people and increasing aging population.
The peripheral neuritis treatment market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to growing number of treatment options, an increasing geriatric population, rising obesity rates, prevalence of HIV/AIDS, growth in generic drug market and government and healthcare initiatives. Major trends in the forecast period include collaboration and partnerships, technological advancement, the rise in diabetic peripheral neuritis treatment product launches, increased focus on personalized medicine, development of non-pharmacological therapies and integration of digital health tools.
Download Your Free Sample PDF:
What strategic initiatives by market players are driving peripheral neuritis treatment industry growth?
The rising prevalence of diabetes is expected to propel the growth of the peripheral neuritis treatment market going forward. Diabetes is a chronic medical condition that occurs when the body is unable to properly regulate blood sugar (glucose) levels. The rising prevalence of diabetes is due to factors such as sedentary lifestyles, unhealthy diets, obesity, aging populations, and genetic predisposition. Peripheral neuritis treatment supports diabetic individuals by relieving nerve pain, reducing inflammation, and enhancing nerve function, helping to improve their quality of life and prevent complications. For instance, in November 2023, according to the American Diabetes Association, a US-based non-profit organization, in 2022, around 25.5 million people in the U.S. were diagnosed with diabetes, accounting for 7.6% of the total population. Therefore, the rising prevalence of diabetes is driving the growth of the peripheral neuritis treatment market.
What emerging segments are shaping the future landscape of the peripheral neuritis treatment industry?
The peripheral neuritis treatment market covered in this report is segmented –
1) By Treatment Type: Pharmacological Therapies, Non Pharmacological Therapies
2) By Drug Class: Anti-Depressants, Anticonvulsants, Local Anesthesia, Analgesics, Steroids, Other Drug Classes
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores
4) By Application: Diabetic Peripheral Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, Other Applications
Subsegments:
1) By Pharmacological Therapies: Pain Relievers (Analgesics), Antidepressants, Anticonvulsants, Topical Medications
2) By Non-Pharmacological Therapies: Physical Therapy, Transcutaneous Electrical Nerve Stimulation (TENS), Acupuncture, Lifestyle And Dietary Modifications
View The Full Market Report:
What future trends will impact the direction of the peripheral neuritis treatment industry?
Major companies in the peripheral neuritis treatment market are focusing on development of innovative treatments such as magnetic peripheral nerve stimulation (mPNS) treatment to enhance nerve regeneration and reduce neuropathic pain. Magnetic peripheral nerve stimulation (mPNS) treatment refers to a non-invasive neuromodulation technique that uses magnetic fields to stimulate peripheral nerves, helping to manage pain, enhance nerve regeneration, and improve motor function in conditions such as neuropathy and musculoskeletal disorders. For instance, in January 2024, Neuralace Medical Inc., a US-based medical equipment manufacturing company announced Axon Therapy (mPNS), for the treatment of chronic painful diabetic neuropathy (PDN) approved by the Food and Drug administration, a US-based government agency. This therapy provides a quick, painless, and non-invasive approach to pain relief. Clinical trials demonstrated a 72.3% responder rate at Day 30 and an 81.4% responder rate at Day 90, highlighting its effectiveness in reducing pain and numbness. This approval marks a significant advancement in pain management, offering patients an alternative to traditional treatments without the side effects of medication.
How are key players in the peripheral neuritis treatment market strengthening their market position?
Major companies operating in the peripheral neuritis treatment market are Pfizer Inc., Johnson & Johnson (J&J), AstraZeneca Plc, Novartis AG, GSK plc, Takeda Pharmaceuticals & Co. Ltd., Eli Lilly and Co., Mallinckrodt Pharmaceuticals plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Apotex Inc., Dr Reddys Laboratories Ltd., Cipla Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Daiichi Sankyo Co. Ltd., Glenmark Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd.
Which geographic areas are contributing significantly to the growth of the peripheral neuritis treatment sector?
North America was the largest region in the peripheral neuritis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral neuritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Peripheral Neuritis Treatment Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
Need Customized Data On Peripheral Neuritis Treatment Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment